A Carnegie Mellon Researcher Raises $35 Million For Clinical Intelligence
Forbes

Carnegie Mellon spinout Xlue secured $35 million in funding from Conviction, Sarah Guo's venture capital firm, to develop AI tools for identifying patients at high risk of cancer.
